https://ibima.eu/en/durvalumab-plus-tremelimumab-for-the-treatment-of-advanced-neuroendocrine-neoplasms-of-gastroenteropancreatic-and-lung-origin-nature-communications/ Sun, 01 Jan 2023 00:00:00 +0000 hourly 1 https://wordpress.org/?v=6.5.5